NEW YORK, May 9 (GenomeWeb News) - Quest Diagnostics will develop new diagnostic tests based on SomaLogic's proprietary aptamer array platform, the companies said last week.
Terms of the deal call for Quest to make a $15 million equity investment in SomaLogic. Additional terms of the arrangement were not disclosed. Timetables for test development were not provided.